Cargando…
Clinical and histopathological features of myositis in systemic lupus erythematosus
OBJECTIVE: The objectives of this study were to compare the clinical features of patients with SLE with and without myopathy and to describe the muscle biopsy features of patients with SLE myopathy. METHODS: This nested case–control study included all subjects enrolled in the Hopkins Lupus Cohort da...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966527/ https://www.ncbi.nlm.nih.gov/pubmed/35351810 http://dx.doi.org/10.1136/lupus-2021-000635 |
_version_ | 1784678663372931072 |
---|---|
author | Tiniakou, Eleni Goldman, Daniel Corse, Andrea Mammen, Andrew Petri, Michelle A |
author_facet | Tiniakou, Eleni Goldman, Daniel Corse, Andrea Mammen, Andrew Petri, Michelle A |
author_sort | Tiniakou, Eleni |
collection | PubMed |
description | OBJECTIVE: The objectives of this study were to compare the clinical features of patients with SLE with and without myopathy and to describe the muscle biopsy features of patients with SLE myopathy. METHODS: This nested case–control study included all subjects enrolled in the Hopkins Lupus Cohort database from May 1987 to June 2016. Subjects with elevated creatine kinase along with evidence of muscle oedema on MRI, myopathic electromyography and/or myopathic muscle biopsy features were defined as having SLE myopathy. Demographic, serological and clinical features were compared between patients with SLE with and without myopathy. Muscle biopsies were histologically classified as polymyositis, dermatomyositis, necrotising myopathy or non-specific myositis. RESULTS: From among 2437 patients with SLE, 179 (7.3%) had myopathy. African American patients were more likely to develop myositis than Caucasian patients (p<0.0001). Compared with those without myopathy, patients with SLE myopathy were more likely to have malar rash (OR 1.67, 1.22–2.29), photosensitivity (OR 1.43, 1.04–1.96), arthritis (OR 1.81, 1.21–2.69), pleurisy (OR 1.77, 1.3–2.42), pericarditis (OR 1.49, 1.06–2.08), acute confusional state (OR 2.07, 1.09–3.94), lymphopaenia (OR 1.64, 1.2–2.24), anti-double-stranded DNA antibodies (OR 1.52, 1.09–2.13), lupus anticoagulant (OR 1.42, 1–2), cognitive impairment (OR 1.87, 1.12–3.13), cataract (OR 1.5, 1.04–2.18), pulmonary hypertension (OR 1.98, 1.13–3.47), pleural fibrosis (OR 2.01, 1.27–3.18), premature gonadal failure (OR 1.9, 1.05–3.43), diabetes (OR 1.92, 1.22–3.02) or hypertension (OR 1.45, 1.06–2). Among 16 muscle biopsies available for review, the most common histological classifications were necrotising myositis (50%) and dermatomyositis (38%). CONCLUSIONS: Patients with SLE myopathy have a higher prevalence of numerous SLE disease manifestations. Necrotising myopathy and dermatomyositis are the most prevalent histopathological features in SLE myopathy. |
format | Online Article Text |
id | pubmed-8966527 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-89665272022-04-19 Clinical and histopathological features of myositis in systemic lupus erythematosus Tiniakou, Eleni Goldman, Daniel Corse, Andrea Mammen, Andrew Petri, Michelle A Lupus Sci Med Epidemiology and Outcomes OBJECTIVE: The objectives of this study were to compare the clinical features of patients with SLE with and without myopathy and to describe the muscle biopsy features of patients with SLE myopathy. METHODS: This nested case–control study included all subjects enrolled in the Hopkins Lupus Cohort database from May 1987 to June 2016. Subjects with elevated creatine kinase along with evidence of muscle oedema on MRI, myopathic electromyography and/or myopathic muscle biopsy features were defined as having SLE myopathy. Demographic, serological and clinical features were compared between patients with SLE with and without myopathy. Muscle biopsies were histologically classified as polymyositis, dermatomyositis, necrotising myopathy or non-specific myositis. RESULTS: From among 2437 patients with SLE, 179 (7.3%) had myopathy. African American patients were more likely to develop myositis than Caucasian patients (p<0.0001). Compared with those without myopathy, patients with SLE myopathy were more likely to have malar rash (OR 1.67, 1.22–2.29), photosensitivity (OR 1.43, 1.04–1.96), arthritis (OR 1.81, 1.21–2.69), pleurisy (OR 1.77, 1.3–2.42), pericarditis (OR 1.49, 1.06–2.08), acute confusional state (OR 2.07, 1.09–3.94), lymphopaenia (OR 1.64, 1.2–2.24), anti-double-stranded DNA antibodies (OR 1.52, 1.09–2.13), lupus anticoagulant (OR 1.42, 1–2), cognitive impairment (OR 1.87, 1.12–3.13), cataract (OR 1.5, 1.04–2.18), pulmonary hypertension (OR 1.98, 1.13–3.47), pleural fibrosis (OR 2.01, 1.27–3.18), premature gonadal failure (OR 1.9, 1.05–3.43), diabetes (OR 1.92, 1.22–3.02) or hypertension (OR 1.45, 1.06–2). Among 16 muscle biopsies available for review, the most common histological classifications were necrotising myositis (50%) and dermatomyositis (38%). CONCLUSIONS: Patients with SLE myopathy have a higher prevalence of numerous SLE disease manifestations. Necrotising myopathy and dermatomyositis are the most prevalent histopathological features in SLE myopathy. BMJ Publishing Group 2022-03-29 /pmc/articles/PMC8966527/ /pubmed/35351810 http://dx.doi.org/10.1136/lupus-2021-000635 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Epidemiology and Outcomes Tiniakou, Eleni Goldman, Daniel Corse, Andrea Mammen, Andrew Petri, Michelle A Clinical and histopathological features of myositis in systemic lupus erythematosus |
title | Clinical and histopathological features of myositis in systemic lupus erythematosus |
title_full | Clinical and histopathological features of myositis in systemic lupus erythematosus |
title_fullStr | Clinical and histopathological features of myositis in systemic lupus erythematosus |
title_full_unstemmed | Clinical and histopathological features of myositis in systemic lupus erythematosus |
title_short | Clinical and histopathological features of myositis in systemic lupus erythematosus |
title_sort | clinical and histopathological features of myositis in systemic lupus erythematosus |
topic | Epidemiology and Outcomes |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966527/ https://www.ncbi.nlm.nih.gov/pubmed/35351810 http://dx.doi.org/10.1136/lupus-2021-000635 |
work_keys_str_mv | AT tiniakoueleni clinicalandhistopathologicalfeaturesofmyositisinsystemiclupuserythematosus AT goldmandaniel clinicalandhistopathologicalfeaturesofmyositisinsystemiclupuserythematosus AT corseandrea clinicalandhistopathologicalfeaturesofmyositisinsystemiclupuserythematosus AT mammenandrew clinicalandhistopathologicalfeaturesofmyositisinsystemiclupuserythematosus AT petrimichellea clinicalandhistopathologicalfeaturesofmyositisinsystemiclupuserythematosus |